These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34446364)
1. MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX). de Wild SR; Simons JM; Vrancken Peeters MTFD; Smidt ML; Koppert LB; Clin Breast Cancer; 2022 Jan; 22(1):e59-e64. PubMed ID: 34446364 [TBL] [Abstract][Full Text] [Related]
2. Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists. Simons JM; Maaskant-Braat AJG; Luiten EJT; Leidenius MHK; van Nijnatten TJA; Boelens PG; Koppert LB; van der Pol CC; van de Velde CJH; Audisio RA; Smidt ML Eur J Surg Oncol; 2020 Jan; 46(1):53-58. PubMed ID: 31434617 [TBL] [Abstract][Full Text] [Related]
3. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative). Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784 [TBL] [Abstract][Full Text] [Related]
4. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study. Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis. Simons JM; van Nijnatten TJA; van der Pol CC; Luiten EJT; Koppert LB; Smidt ML Ann Surg; 2019 Mar; 269(3):432-442. PubMed ID: 30312200 [TBL] [Abstract][Full Text] [Related]
6. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study. van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053 [TBL] [Abstract][Full Text] [Related]
7. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure. van der Noordaa MEM; van Duijnhoven FH; Straver ME; Groen EJ; Stokkel M; Loo CE; Elkhuizen PHM; Russell NS; Vrancken Peeters MTFD Ann Surg Oncol; 2018 Jun; 25(6):1512-1520. PubMed ID: 29511992 [TBL] [Abstract][Full Text] [Related]
8. Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol. van Loevezijn AA; van der Noordaa MEM; Stokkel MPM; van Werkhoven ED; Groen EJ; Loo CE; Elkhuizen PHM; Sonke GS; Russell NS; van Duijnhoven FH; Vrancken Peeters MTFD Breast Cancer Res Treat; 2022 May; 193(1):37-48. PubMed ID: 35239072 [TBL] [Abstract][Full Text] [Related]
9. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793 [TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort study. Schipper RJ; de Bruijn A; van der Sangen MJC; Bloemen JG; van den Hoven I; Schepers EEM; Vriens BEP; Boerman T; Rijkaart DC; van de Winkel LMH; Brouwer C; van Warmerdam LJC; Gielens MPM; van Bommel RMG; van Riet YE; Voogd AC; Nieuwenhuijzen GAP Eur J Surg Oncol; 2024 Sep; 50(9):108472. PubMed ID: 38870876 [TBL] [Abstract][Full Text] [Related]
11. Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy. Koolen BB; Donker M; Straver ME; van der Noordaa MEM; Rutgers EJT; Valdés Olmos RA; Vrancken Peeters MJTFD Br J Surg; 2017 Aug; 104(9):1188-1196. PubMed ID: 28524246 [TBL] [Abstract][Full Text] [Related]
12. This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients. van Hemert AKE; van Duijnhoven FH; Vrancken Peeters MTFD Breast; 2023 Oct; 71():89-95. PubMed ID: 37562108 [TBL] [Abstract][Full Text] [Related]
13. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands. Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791 [TBL] [Abstract][Full Text] [Related]
14. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Donker M; Straver ME; Wesseling J; Loo CE; Schot M; Drukker CA; van Tinteren H; Sonke GS; Rutgers EJ; Vrancken Peeters MJ Ann Surg; 2015 Feb; 261(2):378-82. PubMed ID: 24743607 [TBL] [Abstract][Full Text] [Related]
15. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era. Mann JM; Wu X; Christos P; Nagar H Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423 [TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457 [TBL] [Abstract][Full Text] [Related]
18. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2019 Sep; 30():52-57. PubMed ID: 31500785 [TBL] [Abstract][Full Text] [Related]
19. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211 [TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice. Lee SB; Yu JH; Park H; Kim HJ; Park SH; Chae BJ; Youn HJ; Jung SY; Kim EK; Jung YS; Son BH Asian J Surg; 2019 Jan; 42(1):314-319. PubMed ID: 30049563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]